Bulletin
Investor Alert

NeuroSense Therapeutics Ltd.

NAS: NRSN

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Nov 30, 2022, 3:44 p.m.

/zigman2/quotes/230850337/composite

$

1.72

Change

+0.04 +2.37%

Volume

Volume 9,332

Quotes are delayed by 20 min

/zigman2/quotes/230850337/composite

Previous close

$ 1.68

$ 1.72

Change

+0.04 +2.37%

Day low

Day high

$1.68

$1.74

Open

52 week low

52 week high

$1.23

$8.18

Open

Annual Financials for NeuroSense Therapeutics Ltd.

Fiscal year is January-December. All values USD millions. 201920202021 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A ---3,0003,000
COGS excluding D&A -----
Depreciation & Amortization Expense ---3,0003,000
Depreciation ---3,0003,000
Amortization of Intangibles -----
Gross Income ---(3,000)(3,000)
201920202021 5-year trend
SG&A Expense --1.24M2.89M5.58M
Research & Development --898,0002.5M3.08M
Other SG&A -----
Other Operating Expense -----
Unusual Expense ----(2.73M)
EBIT after Unusual Expense ----(2.86M)
Non Operating Income/Expense --(5,000)(1,000)(32,000)
Non-Operating Interest Income --18,00061,000-
Equity in Affiliates (Pretax) -----
Interest Expense ----1.15M
Gross Interest Expense ----1.15M
Interest Capitalized -----
Pretax Income --(1.22M)(2.83M)(4.04M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income --(1.22M)(2.83M)(4.04M)
Minority Interest Expense -----
Net Income --(1.22M)(2.83M)(4.04M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries --(1.22M)(2.83M)(4.04M)
Preferred Dividends -----
Net Income Available to Common --(1.22M)(2.83M)(4.04M)
EPS (Basic) --(0.63)(1.46)(2.08)
Basic Shares Outstanding --1.94M1.94M1.94M
EPS (Diluted) --(0.63)(1.46)(2.08)
Diluted Shares Outstanding --1.94M1.94M1.94M
EBITDA ---(2.89M)(5.58M)
Link to MarketWatch's Slice.